ストックスクリーナーアプリを入手
1.8551
4.38%
-0.0849
前日終値:
$1.94
開ける：
$1.93
24時間の取引高:
655.41K
Relative Volume:
0.37
時価総額：
$722.18M
収益：
$106.34M
当期純損益:
$-74.66M
株価収益率:
-1.7501
EPS:
-1.06
ネットキャッシュフロー:
$-46.12M
1週間 パフォーマンス:
+8.48%
1か月 パフォーマンス:
-6.78%
6か月 パフォーマンス:
-25.20%
1年 パフォーマンス:
-28.65%
1日の値動き範囲:
$1.82
$1.95
1週間の範囲:
$1.715
$1.96
52週間の値動き範囲:
$1.21
$3.04
Standard Biotools Inc Stock (LAB) Company Profile
名前
Standard Biotools Inc
セクター
電話
(650) 266-6000
住所
2 TOWER PLACE, SOUTH SAN FRANCISCO
LAB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LAB
Standard Biotools Inc
|
1.855 | 722.18M | 106.34M | -74.66M | -46.12M | -0.95 |
|
ABT
Abbott Laboratories
|
116.98 | 202.27B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
388.25 | 149.49B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
90.23 | 133.10B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
85.89 | 110.14B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
69.95 | 41.60B | 6.60B | 4.16B | 490.10M | 6.93 |
Standard Biotools Inc Stock (LAB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-04-16 | 開始されました | TD Cowen | Buy |
| 2024-04-04 | 開始されました | Jefferies | Buy |
| 2023-07-12 | 開始されました | KeyBanc Capital Markets | Overweight |
Standard Biotools Inc (LAB) 最新ニュース
Standard BioTools (STU:FLB) Enterprise Value : €386.4 Mil (As of Nov. 30, 2024) - GuruFocus.com
Standard BioTools Inc. (NASDAQ:LAB) Short Interest Down 24.9% in November - MarketBeat
Standard BioTools (NASDAQ:LAB) Shares Gap UpShould You Buy? - MarketBeat
Standard BioTools (NASDAQ:LAB) adds US$78m to market cap in the past 7 days, though investors from three years ago are still down 59% - Simply Wall St
Sumitomo Mitsui Trust Group Inc. Decreases Holdings in Standard BioTools Inc. (NASDAQ:LAB) - MarketBeat
Indaba Capital Management L.P. Acquires New Stake in Standard Bi - GuruFocus.com
Creative Planning Purchases Shares of 20,328 Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools names new CFO By Investing.com - Investing.com Australia
ARK Investment Management LLC Lowers Stock Holdings in Standard BioTools Inc. (NASDAQ:LAB) - MarketBeat
Standard BioTools (STU:FLB) Price-to-Operating-Cash-Flow : (As of Nov. 07, 2024) - GuruFocus.com
Standard BioTools (STU:FLB) Revenue per Share : €0.67 (TTM As of Sep. 2024) - GuruFocus.com
Standard BioTools appoints Kim as Chief Financial Officer - TipRanks
Standard BioTools names new CFO - Investing.com
Standard BioTools Names Alex Kim as New CFO - TipRanks
Standard BioTools Appoints Alex Kim as Chief Financial Officer - GlobeNewswire
Standard BioTools Names Co-Founder Alex Kim as CFO, Brings 30-Year Industry Expertise | LAB Stock News - StockTitan
Form 10-Q STANDARD BIOTOOLS INC. For: Sep 30 - StreetInsider.com
Vanguard Group Inc's Strategic Acquisition in Standard BioTools Inc - GuruFocus.com
Earnings Release: Here's Why Analysts Cut Their Standard BioTools Inc. (NASDAQ:LAB) Price Target To US$3.17 - Yahoo Finance
TD Cowen trims Standard BioTools target, sees upside in margins and SomaScan performance - Investing.com Australia
Standard BioTools Q3 2024 Earnings Preview - MSN
Standard BioTools Third Quarter 2024 Earnings: Beats Expectations - Simply Wall St
Earnings call: Standard BioTools faces mixed Q3 results amid market challenges - Investing.com Australia
Standard BioTools Inc (LAB) Q3 2024 Earnings Call Highlights: Navigating Market Challenges with ... - Yahoo Finance
Standard BioTools Inc (LAB) Q3 2024 Earnings Call Highlights: Navigating Market Challenges with ... By GuruFocus - Investing.com Canada
Standard BioTools Inc. (NASDAQ:LAB) Q3 2024 Earnings Call Transcript - Insider Monkey
Standard BioTools price target lowered to $2.50 from $2.75 at TD Cowen - TipRanks
Standard BioTools to Participate in Upcoming Investor Conferences - The Manila Times
Standard Biotools earnings beat by $0.02, revenue topped estimates - Investing.com Canada
Standard BioTools Inc. Reports Q3 2024 Financial Performance - TipRanks
Standard BioTools: Q3 Earnings Snapshot - mySA
Standard BioTools reports Q3 EPS (7c), consensus (9c) - TipRanks
Standard BioTools (LAB) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Standard BioTools Reports Strong Q3 2024 Performance - TipRanks
Standard BioTools, SomaLogic fall after shareholder nod for merger - MSN
Standard BioTools Reports Third Quarter 2024 Financial Results - The Manila Times
Standard BioTools Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Standard BioTools (NASDAQ:LAB) Trading 5.9% HigherShould You Buy? - MarketBeat
Standard BioTools And 2 Other Penny Stocks Executives Are Buying - MSN
Standard BioTools (NASDAQ:LAB) Has Debt But No Earnings; Should You Worry? - Simply Wall St
Standard BioTools (LAB) to Release Earnings on Wednesday - MarketBeat
Millennium Management LLC Acquires Shares in Standard BioTools I - GuruFocus.com
Millennium Management LLC Acquires Shares in Standard BioTools Inc - Yahoo Finance
LABStandard BioTools Inc. Latest Stock News & Market Updates - StockTitan
Standard BioTools Announces Conference Call and Webcast for - GlobeNewswire
Standard BioTools Announces Conference Call and Webcast for Third Quarter 2024 Financial Results on October 30, 2024 - StockTitan
Get in on Standard BioTools Inc’s (LAB) buy-in window today! - SETE News
Financial Analysis: Standard BioTools Inc (LAB)’s Ratios Unveil Key Insights - The Dwinnex
A Guide To The Risks Of Investing In Standard BioTools Inc (LAB) - Knox Daily
Standard Biotools Inc (LAB) 財務データ
収益
当期純利益
現金流量
EPS
0.31%
0.19%
大文字化:
|
ボリューム (24 時間):